(NASDAQ: ALEC) Alector's forecast annual revenue growth rate of 7.24% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.7%.
Alector's revenue in 2025 is $61,508,000.On average, 3 Wall Street analysts forecast ALEC's revenue for 2025 to be $4,289,448,099, with the lowest ALEC revenue forecast at $1,958,652,100, and the highest ALEC revenue forecast at $6,013,061,947. On average, 2 Wall Street analysts forecast ALEC's revenue for 2026 to be $1,686,889,121, with the lowest ALEC revenue forecast at $1,415,126,142, and the highest ALEC revenue forecast at $1,958,652,100.
In 2027, ALEC is forecast to generate $11,005,666,150 in revenue, with the lowest revenue forecast at $11,005,666,150 and the highest revenue forecast at $11,005,666,150.